These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23451025

  • 41. Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR.
    Kim EJ, Kim BC, Kim SJ, Jung DS, Sin JS, Yoon YJ, Chin J, Lee KH, Na DL.
    Dement Geriatr Cogn Disord; 2012; 34(5-6):300-6. PubMed ID: 23208196
    [Abstract] [Full Text] [Related]

  • 42. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory.
    Konstantinopoulou E, Aretouli E, Ioannidis P, Karacostas D, Kosmidis MH.
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):939-46. PubMed ID: 23135894
    [Abstract] [Full Text] [Related]

  • 43. Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.
    Tahmasian M, Shao J, Meng C, Grimmer T, Diehl-Schmid J, Yousefi BH, Förster S, Riedl V, Drzezga A, Sorg C.
    J Nucl Med; 2016 Mar; 57(3):410-5. PubMed ID: 26585059
    [Abstract] [Full Text] [Related]

  • 44. Presenting neuropsychological testing profile of autopsy-confirmed frontotemporal lobar degeneration.
    Yoshizawa H, Vonsattel JP, Honig LS.
    Dement Geriatr Cogn Disord; 2013 Mar; 36(5-6):279-89. PubMed ID: 23949428
    [Abstract] [Full Text] [Related]

  • 45. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.
    Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL.
    Lancet Neurol; 2008 Feb; 7(2):129-35. PubMed ID: 18191617
    [Abstract] [Full Text] [Related]

  • 46. Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
    Benussi A, Karikari TK, Ashton N, Gazzina S, Premi E, Benussi L, Ghidoni R, Rodriguez JL, Emeršič A, Simrén J, Binetti G, Fostinelli S, Giunta M, Gasparotti R, Zetterberg H, Blennow K, Borroni B.
    J Neurol Neurosurg Psychiatry; 2020 Sep; 91(9):960-967. PubMed ID: 32611664
    [Abstract] [Full Text] [Related]

  • 47. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
    Kurland BF, Muzi M, Peterson LM, Doot RK, Wangerin KA, Mankoff DA, Linden HM, Kinahan PE.
    J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
    [Abstract] [Full Text] [Related]

  • 48. Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
    Nestor PJ, Altomare D, Festari C, Drzezga A, Rivolta J, Walker Z, Bouwman F, Orini S, Law I, Agosta F, Arbizu J, Boccardi M, Nobili F, Frisoni GB, EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1509-1525. PubMed ID: 29736698
    [Abstract] [Full Text] [Related]

  • 49. Social conceptual impairments in frontotemporal lobar degeneration with right anterior temporal hypometabolism.
    Zahn R, Moll J, Iyengar V, Huey ED, Tierney M, Krueger F, Grafman J.
    Brain; 2009 Mar; 132(Pt 3):604-16. PubMed ID: 19153155
    [Abstract] [Full Text] [Related]

  • 50. Comparing the driving behaviours of individuals with frontotemporal lobar degeneration and those with Alzheimer's disease.
    Fujito R, Kamimura N, Ikeda M, Koyama A, Shimodera S, Morinobu S, Inoue S.
    Psychogeriatrics; 2016 Jan; 16(1):27-33. PubMed ID: 25735319
    [Abstract] [Full Text] [Related]

  • 51. Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
    Oeckl P, Steinacker P, Feneberg E, Otto M.
    J Neurochem; 2016 Aug; 138 Suppl 1():184-92. PubMed ID: 27186717
    [Abstract] [Full Text] [Related]

  • 52. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F, Bier JC, Genevrois C, Mendlewicz J, Lotstra F.
    Encephale; 2003 Aug; 29(2):172-80. PubMed ID: 14567169
    [Abstract] [Full Text] [Related]

  • 53. Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration.
    Chen Q, Kantarci K.
    Front Neurol; 2020 Aug; 11():80. PubMed ID: 32184751
    [Abstract] [Full Text] [Related]

  • 54. Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
    Caroppo P, Habert MO, Durrleman S, Funkiewiez A, Perlbarg V, Hahn V, Bertin H, Gaubert M, Routier A, Hannequin D, Deramecourt V, Pasquier F, Rivaud-Pechoux S, Vercelletto M, Edouart G, Valabregue R, Lejeune P, Didic M, Corvol JC, Benali H, Lehericy S, Dubois B, Colliot O, Brice A, Le Ber I, Predict-PGRN study group.
    J Alzheimers Dis; 2015 Aug; 47(3):751-9. PubMed ID: 26401709
    [Abstract] [Full Text] [Related]

  • 55. Comparison of analytical methods of brain [18F]FDG-PET after severe traumatic brain injury.
    Madsen K, Hesby S, Poulsen I, Fuglsang S, Graff J, Larsen KB, Kammersgaard LP, Law I, Siebner HR.
    J Neurosci Methods; 2017 Nov 01; 291():176-181. PubMed ID: 28811199
    [Abstract] [Full Text] [Related]

  • 56. From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers.
    Hales CM, Hu WT.
    Int Rev Psychiatry; 2013 Apr 01; 25(2):210-20. PubMed ID: 23611350
    [Abstract] [Full Text] [Related]

  • 57. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D, Bielle F, Plu I, Duyckaerts C.
    Rev Neurol (Paris); 2013 Oct 01; 169(10):786-92. PubMed ID: 24035575
    [Abstract] [Full Text] [Related]

  • 58. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
    Liu J, Li C, Hu M, Lu J, Shi X, Xing L, Sun X, Fu Z, Yu J, Meng X.
    Medicine (Baltimore); 2015 May 01; 94(17):e678. PubMed ID: 25929896
    [Abstract] [Full Text] [Related]

  • 59. Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease.
    Ibach B, Poljansky S, Marienhagen J, Sommer M, Männer P, Hajak G.
    Neuroimage; 2004 Oct 01; 23(2):739-43. PubMed ID: 15488423
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.